These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

162 related articles for article (PubMed ID: 12064478)

  • 1. Cdk5 phosphorylates p53 and regulates its activity.
    Zhang J; Krishnamurthy PK; Johnson GV
    J Neurochem; 2002 Apr; 81(2):307-13. PubMed ID: 12064478
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Induction of cyclin-dependent kinase 5 and its activator p35 through the extracellular-signal-regulated kinase and protein kinase A pathways during retinoic-acid mediated neuronal differentiation in human neuroblastoma SK-N-BE(2)C cells.
    Lee JH; Kim KT
    J Neurochem; 2004 Nov; 91(3):634-47. PubMed ID: 15485494
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Involvement of Cdk5/p25 in digoxin-triggered prostate cancer cell apoptosis.
    Lin H; Juang JL; Wang PS
    J Biol Chem; 2004 Jul; 279(28):29302-7. PubMed ID: 15123618
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Subtype-selective induction of wild-type p53 and apoptosis, but not cell cycle arrest, by human somatostatin receptor 3.
    Sharma K; Patel YC; Srikant CB
    Mol Endocrinol; 1996 Dec; 10(12):1688-96. PubMed ID: 8961277
    [TBL] [Abstract][Full Text] [Related]  

  • 5. p25/Cdk5-mediated retinoblastoma phosphorylation is an early event in neuronal cell death.
    Hamdane M; Bretteville A; Sambo AV; Schindowski K; Bégard S; Delacourte A; Bertrand P; Buée L
    J Cell Sci; 2005 Mar; 118(Pt 6):1291-8. PubMed ID: 15741232
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Potent induction of wild-type p53-dependent transcription in tumour cells by a synthetic inhibitor of cyclin-dependent kinases.
    Kotala V; Uldrijan S; Horky M; Trbusek M; Strnad M; Vojtesek B
    Cell Mol Life Sci; 2001 Aug; 58(9):1333-9. PubMed ID: 11577989
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Adenovirus-mediated E2F-1 gene transfer induces an apoptotic response in human gastric carcinoma cells that is enhanced by cyclin dependent kinase inhibitors.
    Atienza C; Elliott MJ; Dong YB; Yang HL; Stilwell A; Liu TJ; McMasters KM
    Int J Mol Med; 2000 Jul; 6(1):55-63. PubMed ID: 10851267
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Hepatitis B virus-X protein upregulates the expression of p21waf1/cip1 and prolongs G1-->S transition via a p53-independent pathway in human hepatoma cells.
    Park US; Park SK; Lee YI; Park JG; Lee YI
    Oncogene; 2000 Jul; 19(30):3384-94. PubMed ID: 10918595
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Interplay between the p53 tumor suppressor protein family and Cdk5: novel therapeutic approaches for the treatment of neurodegenerative diseases using selective Cdk inhibitors.
    Schmid G; Strosznajder JB; Wesierska-Gadek J
    Mol Neurobiol; 2006 Aug; 34(1):27-50. PubMed ID: 17003520
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Biochemical and cellular effects of roscovitine, a potent and selective inhibitor of the cyclin-dependent kinases cdc2, cdk2 and cdk5.
    Meijer L; Borgne A; Mulner O; Chong JP; Blow JJ; Inagaki N; Inagaki M; Delcros JG; Moulinoux JP
    Eur J Biochem; 1997 Jan; 243(1-2):527-36. PubMed ID: 9030781
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Inhibition of aberrant cyclin-dependent kinase 5 activity attenuates isoflurane neurotoxicity in the developing brain.
    Wang WY; Luo Y; Jia LJ; Hu SF; Lou XK; Shen SL; Lu H; Zhang HH; Yang R; Wang H; Ma ZW; Xue QS; Yu BW
    Neuropharmacology; 2014 Feb; 77():90-9. PubMed ID: 24055498
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Nerve growth factor withdrawal-mediated apoptosis in naive and differentiated PC12 cells through p53/caspase-3-dependent and -independent pathways.
    Vaghefi H; Hughes AL; Neet KE
    J Biol Chem; 2004 Apr; 279(15):15604-14. PubMed ID: 14739302
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Cdk5 inhibits anterograde axonal transport of neurofilaments but not that of tau by inhibition of mitogen-activated protein kinase activity.
    Moran CM; Donnelly M; Ortiz D; Pant HC; Mandelkow EM; Shea TB
    Brain Res Mol Brain Res; 2005 Apr; 134(2):338-44. PubMed ID: 15836929
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Influence of phosphorylation of p35, an activator of cyclin-dependent kinase 5 (cdk5), on the proteolysis of p35.
    Kerokoski P; Suuronen T; Salminen A; Soininen H; Pirttilä T
    Brain Res Mol Brain Res; 2002 Oct; 106(1-2):50-6. PubMed ID: 12393264
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Neuronal cyclin-dependent kinase 5: role in nervous system function and its specific inhibition by the Cdk5 inhibitory peptide.
    Kesavapany S; Li BS; Amin N; Zheng YL; Grant P; Pant HC
    Biochim Biophys Acta; 2004 Mar; 1697(1-2):143-53. PubMed ID: 15023357
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Adenovirus-mediated expression of p53 or p21 in a papillary serous endometrial carcinoma cell line (SPEC-2) results in both growth inhibition and apoptotic cell death: potential application of gene therapy to endometrial cancer.
    Ramondetta L; Mills GB; Burke TW; Wolf JK
    Clin Cancer Res; 2000 Jan; 6(1):278-84. PubMed ID: 10656459
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Dual action of cyclin-dependent kinase inhibitors: induction of cell cycle arrest and apoptosis. A comparison of the effects exerted by roscovitine and cisplatin.
    Wesierska-Gadek J; Gueorguieva M; Horky M
    Pol J Pharmacol; 2003; 55(5):895-902. PubMed ID: 14704484
    [TBL] [Abstract][Full Text] [Related]  

  • 18. A novel mechanism of non-Aβ component of Alzheimer's disease amyloid (NAC) neurotoxicity. Interplay between p53 protein and cyclin-dependent kinase 5 (Cdk5).
    Kaźmierczak A; Czapski GA; Adamczyk A; Gajkowska B; Strosznajder JB
    Neurochem Int; 2011 Feb; 58(2):206-14. PubMed ID: 21130128
    [TBL] [Abstract][Full Text] [Related]  

  • 19. p35/cdk5 binds and phosphorylates beta-catenin and regulates beta-catenin/presenilin-1 interaction.
    Kesavapany S; Lau KF; McLoughlin DM; Brownlees J; Ackerley S; Leigh PN; Shaw CE; Miller CC
    Eur J Neurosci; 2001 Jan; 13(2):241-7. PubMed ID: 11168528
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Different mechanisms for inhibition of cell proliferation via cell cycle proteins in PC12 cells by nerve growth factor and staurosporine.
    Gollapudi L; Neet KE
    J Neurosci Res; 1997 Aug; 49(4):461-74. PubMed ID: 9285522
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.